Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study

NCT04569760 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT04569760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04569760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
Lead sponsor
McMaster University
Phase
Phase 3
Overall status
Withdrawn
Start date
April 30, 2021
Completion date
June 30, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agoraphobia, generalized anxiety disorder, panic disorder, social anxiety disorder